EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption

Pietro B Faré iD, Gabriela Ziltener, Judith Bergadà Pijuan iD, Irene A Abela iD, Britta L Hirsch, Michael Huber iD, Johannes Nemeth, Huldrych F Günthard iD

Viruses · 2025

DOI: 10.3390/v17050699 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Viruses, 2025. Verfasst von Pietro B Faré und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Drug Resistance, Viral, Heterocyclic Compounds, 4 or More Rings. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yvonne Jacob Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A treatment-experienced, highly adherent person living with HIV for over 25 years developed resistance mutations against all four major ART classes, including bictegravir (BIC). This led to viral failure on a quadruple regimen including BIC and doravirine (DOR). Resistance emergence was associated with M184V, thymidine analog mutations (TAMs), NNRTI mutations (108I, 234I, 318F), and INSTI mutations (T97A, G140S, Q148H, G149A), likely driven by suboptimal BIC levels due to divalent cation interactions. During a two-month ART interruption, the resistant virus was rapidly replaced by an ancient wild-type strain. Despite resistance to all four ART classes, a genotype-adapted salvage regimen, including fostemsavir, achieved viral suppression within seven months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV-1Drug Resistance, ViralHeterocyclic Compounds, 4 or More RingsAnti-HIV AgentsHumansMutationMalePyridonesAmidesGenotypeTreatment InterruptionHeterocyclic Compounds, 3-RingPiperazines

Stichwörter der Autor:innen

ART interruptionHIV-1M184V/I mutationantiretroviral therapybictegravirdrug resistanceintegrase strand transfer inhibitorvirological failurewild-type re-emergence

Substanzen

bictegravirHeterocyclic Compounds, 4 or More RingsAnti-HIV AgentsPyridonesAmidesHeterocyclic Compounds, 3-RingPiperazines

Autor:innen und Institutionen

  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.

ORCID-Profile: Pietro B Faré, Judith Bergadà Pijuan, Irene A Abela, Michael Huber, Huldrych F Günthard

Förderung

  • Yvonne Jacob Foundation

Zitieren

APA

Faré, P. B., Ziltener, G., Bergadà Pijuan, J., Abela, I. A., Hirsch, B. L., Huber, M., Nemeth, J., & Günthard, H. F. (2025). Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption. Viruses. https://doi.org/10.3390/v17050699

Vancouver

Faré PB, Ziltener G, Bergadà Pijuan J, Abela IA, Hirsch BL, Huber M, et al. Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption. Viruses. 2025. doi:10.3390/v17050699

BibTeX
@article{Far2025,
  author = {Faré, Pietro B and Ziltener, Gabriela and Bergadà Pijuan, Judith and Abela, Irene A and Hirsch, Britta L and Huber, Michael and Nemeth, Johannes and Günthard, Huldrych F},
  title = {Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17050699}
}
Kostenlos starten →